企業プロフィール
Avenue Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- ATXI
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.26 USD (-8.21%)
終値
最終更新: 2026年8月14日
—
時価総額
株価変動の要因
Current closing-price context is not available for ATXI.
企業概要
事業概要
Avenue Therapeutics is a specialty pharmaceutical company focused on acute and hospital-based pain management. Its story revolves around trying to bring differentiated pain treatments into controlled clinical settings.
所在地とセクター分類
Avenue Therapeutics is headquartered in the United States and listed on NASDAQ. It sits in specialty pharma and acute-care pain management.
ビジネスモデルの特徴
The company depends on clinical and regulatory progress, commercial strategy, and the ability to sustain a narrow product focus. Investors track trial updates, development milestones, and capital runway.
バイオ業界での位置付け
Avenue occupies a small acute-pain niche within specialty pharma. The stock tends to move on regulatory news and the market's view of the company’s ability to commercialize in a difficult category.
今後のカタリスト
- Avenue Therapeutics is largely a legacy and closeout story now, so the catalysts are any strategic or asset-resolution update rather than a live pipeline event. The market is mainly focused on residual value.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。